KIM
58
4
PRU
51
6
MHK
55
15
UA
33
3
AMT
46
4
UNM
68
2
T
45
7
DG
24
-4
OI
49
4
XOM
54
6
AMP
69
2
IR
82
2
IFF
47
5
NVDA
60
-9
MMM
30
4
FLS
55
3
TGNA
48
6
GILD
26
2
IRM
62
2
LOW
56
4
KIM
58
4
PRU
51
6
MHK
55
15
UA
33
3
AMT
46
4
UNM
68
2
T
45
7
DG
24
-4
OI
49
4
XOM
54
6
AMP
69
2
IR
82
2
IFF
47
5
NVDA
60
-9
MMM
30
4
FLS
55
3
TGNA
48
6
GILD
26
2
IRM
62
2
LOW
56
4
Financhill
Back

Beam Therapeutics Quote, Financials, Valuation and Earnings

The little-known AI stock you need to read about now...

Get the name - FREE.
Sell
28

BEAM
Beam Therapeutics

Last Price:
22.05
Seasonality Move:
25.98%

7 Day Trial

ALL ACCESS PASS

$ 7

Master the Market: The Formula for a 96.3% Win Rate Revealed!

Act now!

Beam Therapeutics Price Quote

$22.05

Beam Therapeutics Key Stats

Sell
28
Beam Therapeutics (BEAM) is a Sell
Day range:
$21.52 - $22.68
52-week range:
$16.95 - $49.50
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
4.50
P/B ratio:
1.83%
Volume:
882.9K
Avg. volume:
1.4M
1-year change:
-28.2%
Market cap:
$1.8B
Revenue:
$377.7M
EPS:
$-1.9

How Much Does Beam Therapeutics Make?

Is Beam Therapeutics Growing As A Company?

  • What Is Beam Therapeutics's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 14.78%
  • What Is Beam Therapeutics's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

Beam Therapeutics Stock Price Performance

  • Did Beam Therapeutics Stock Go Up Last Month?
    Beam Therapeutics share price went down by -33.26% last month
  • Did BEAM's Share Price Rise Over The Last Year?
    BEAM share price fell by -28.2% over the past 1 year

What Is Beam Therapeutics 52-Week High & Low?

Beam Therapeutics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Beam Therapeutics?

  • How Much Debt Does Beam Therapeutics Have?
    Total long term debt quarterly is $0
  • How Much Cash Does Beam Therapeutics Have?
    Cash and short term investments quarterly total is $1.2B
  • What Is Beam Therapeutics’s Book Value Per Share?
    Book value per share is 12.02

Is Beam Therapeutics Cash Flow Positive?

  • What Is BEAM Cash Flow From Operations?
    Cash flow from operations (TTM) is -$149.2M
  • What Is Beam Therapeutics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $276.4M
  • What Is Beam Therapeutics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $71.8M

Beam Therapeutics Return On Invested Capital

  • Is Management Doing A Good Job?
    BEAM return on invested capital is -16.29%
  • What Is Beam Therapeutics Return On Assets?
    ROA measures how assets are converting to revenues and is -9.78%
  • What Is BEAM Return On Equity?
    ROE is a measure of profitability and is -16.29%

Beam Therapeutics Earnings Date & Stock Price

Beam Therapeutics Competitors

Beam Therapeutics Dividend Yield

Data Unavailable

Beam Therapeutics Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 343.61%
Revenue: 1478.04% 839.01%

Analyst Recommendations

Buy Recommendations: 6
Hold Recommendations: 7
Sell Recommendations: 0
Price Target: 49.54
Upside from Last Price: 124.66%

Major Shareholders

  • How many BEAM shares are owned by institutional investors?
    95M BEAM shares are owned by institutional investors
  • How many BEAM shares are owned by insiders?
    1.5M BEAM shares are owned by insiders